Under construction – not a live service
Sign in

NCT04909008Suspended

Exercise Training to Improve Cardiopulmonary Hemodynamics in Heart Failure Patients

Exercise Training to Improve Pulmonary Haemodynamic and Right Ventricular Function in Heart Failure Patients With Pulmonary Hypertension

Source: ClinicalTrials.gov · Last updated 4 May 2026

Reason given: Lack of recruitment

Brief summary (registry, in English)

This research study is being done to find out if exercise therapy can help improve the heart function, overall health, and quality of life of patients with pulmonary hypertension caused by heart failure.

Status (registry)
Suspended
Study type
Interventional
Enrollment
40 (estimated)
First submitted
26 May 2021
Start date
1 Jan 2024
Primary completion date
1 Apr 2025
Lead sponsor
Mayo Clinic
NCT number
NCT04909008

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Comorbidities such as obesity (BMI >36), uncontrolled systemic hypertension, type 2 diabetes, and COPD (FEV1 <50%).
  • Musculoskeletal or other conditions that would limit exercise participation.

Other

  • NYHA class IV HF.
  • Diagnosis of diastolic HF.
  • Pregnant or nursing women

Who the study is looking for

  • NYHA functional class I-IIIb.
  • LVEF < 40%.
  • Clinically-stable for > 3 months [no change in disease status or medication].
  • Willing and able to provide written informed consent and perform cycle-ergometer or treadmill based exercise.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Mayo Clinic in FloridaJacksonvilleUnited StatesUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.